| # | Title | Journal | Year | Citations |
|---|
| 1 | Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies | Lancet, The | 2002 | 1,415 |
| 2 | Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy | JAMA - Journal of the American Medical Association | 2016 | 1,076 |
| 3 | Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study | Gastroenterology | 2010 | 1,056 |
| 4 | Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study | Lancet, The | 1999 | 894 |
| 5 | Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study | Lancet, The | 2005 | 526 |
| 6 | Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study | Lancet, The | 2014 | 430 |
| 7 | Zoonotic Potential of the Microsporidia | Clinical Microbiology Reviews | 2005 | 413 |
| 8 | Common Genetic Variation and the Control of HIV-1 in Humans | PLoS Genetics | 2009 | 377 |
| 9 | Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study | Lancet Infectious Diseases, The | 2011 | 345 |
| 10 | Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study | HIV Medicine | 2013 | 329 |
| 11 | Early and nonreversible decrease of CD161++/MAIT cells in HIV infection | Blood | 2013 | 307 |
| 12 | Whole Genome Deep Sequencing of HIV-1 Reveals the Impact of Early Minor Variants Upon Immune Recognition During Acute Infection | PLoS Pathogens | 2012 | 306 |
| 13 | Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study | British Journal of Cancer | 2010 | 276 |
| 14 | Healthcare-associated prosthetic heart valve, aortic vascular graft, and disseminatedMycobacterium chimaerainfections subsequent to open heart surgery | European Heart Journal | 2015 | 216 |
| 15 | Analysis of the Mechanism by Which the Small-Molecule CCR5 Antagonists SCH-351125 and SCH-350581 Inhibit Human Immunodeficiency Virus Type 1 Entry | Journal of Virology | 2003 | 200 |
| 16 | Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study | Lancet HIV,the | 2018 | 155 |
| 17 | Broad-Range 16S rRNA Gene Polymerase Chain Reaction for Diagnosis of Culture-Negative Bacterial Infections | Clinical Infectious Diseases | 2011 | 152 |
| 18 | Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy | Infection | 2011 | 146 |
| 19 | ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Intracellular signaling pathways: tyrosine kinase and mTOR inhibitors) | Clinical Microbiology and Infection | 2018 | 142 |
| 20 | 24 Hours in the Life of HIV-1 in a T Cell Line | PLoS Pathogens | 2013 | 134 |
| 21 | The Impact of Infection on Chronic Allograft Dysfunction and Allograft Survival After Solid Organ Transplantation | American Journal of Transplantation | 2015 | 131 |
| 22 | Ambiguous Nucleotide Calls From Population-based Sequencing of HIV-1 are a Marker for Viral Diversity and the Age of Infection | Clinical Infectious Diseases | 2011 | 127 |
| 23 | Full-length haplotype reconstruction to infer the structure of heterogeneous virus populations | Nucleic Acids Research | 2014 | 126 |
| 24 | Voriconazole Concentration in Human Aqueous Humor and Plasma during Topical or Combined Topical and Systemic Administration for Fungal Keratitis | Antimicrobial Agents and Chemotherapy | 2007 | 115 |
| 25 | Effect of Mutation and Genetic Background on Drug Resistance in Mycobacterium tuberculosis | Antimicrobial Agents and Chemotherapy | 2012 | 115 |
| 26 | Prolonged bacterial lag time results in small colony variants that represent a sub-population of persisters | Nature Communications | 2018 | 109 |
| 27 | Phylogenetic Approach Reveals That Virus Genotype Largely Determines HIV Set-Point Viral Load | PLoS Pathogens | 2010 | 108 |
| 28 | Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing | Journal of Antimicrobial Chemotherapy | 2015 | 102 |
| 29 | Hepatitis delta-associated mortality in HIV/HBV-coinfected patients | Journal of Hepatology | 2017 | 101 |
| 30 | Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaboration | BMC Medicine | 2016 | 100 |
| 31 | MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1 | Journal of Experimental Medicine | 2011 | 95 |
| 32 | Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodies | Journal of Experimental Medicine | 2011 | 92 |
| 33 | Characteristics and outcome of 16 periprosthetic shoulder joint infections | Infection | 2013 | 92 |
| 34 | The Incidence of AIDS-Defining Illnesses at a Current CD4 Count ≥200 Cells/µL in the Post–Combination Antiretroviral Therapy Era | Clinical Infectious Diseases | 2013 | 92 |
| 35 | CD161 Defines a Functionally Distinct Subset of Pro-Inflammatory Natural Killer Cells | Frontiers in Immunology | 2018 | 91 |
| 36 | Impact of Antiviral Preventive Strategies on the Incidence and Outcomes of Cytomegalovirus Disease in Solid Organ Transplant Recipients | American Journal of Transplantation | 2013 | 90 |
| 37 | Optimal Length of Cultivation Time for Isolation of Propionibacterium acnes in Suspected Bone and Joint Infections Is More than 7 Days | Journal of Clinical Microbiology | 2016 | 90 |
| 38 | Association of Pharmacogenetic Markers with Premature Discontinuation of First-line Anti-HIV Therapy: An Observational Cohort Study | Journal of Infectious Diseases | 2011 | 89 |
| 39 | Atazanavir is not associated with an increased risk of cardio or cerebrovascular disease events | Aids | 2013 | 89 |
| 40 | Higher CNS Penetration-Effectiveness of Long-term Combination Antiretroviral Therapy Is Associated With Better HIV-1 Viral Suppression in Cerebrospinal Fluid | Journal of Acquired Immune Deficiency Syndromes (1999) | 2013 | 86 |
| 41 | Antibiotics Stimulate Formation of Vesicles in Staphylococcus aureus in both Phage-Dependent and -Independent Fashions and via Different Routes | Antimicrobial Agents and Chemotherapy | 2019 | 86 |
| 42 | Profound Depletion of HIV-1 Transcription in Patients Initiating Antiretroviral Therapy during Acute Infection | PLoS ONE | 2010 | 84 |
| 43 | Frequency and Determinants of Unprotected Sex among HIV‐Infected Persons: The Swiss HIV Cohort Study | Clinical Infectious Diseases | 2010 | 83 |
| 44 | Infections With the Tick-Borne Bacterium "Candidatus Neoehrlichia mikurensis" Mimic Noninfectious Conditions in Patients With B Cell Malignancies or Autoimmune Diseases | Clinical Infectious Diseases | 2014 | 79 |
| 45 | Host and Viral Genetic Correlates of Clinical Definitions of HIV-1 Disease Progression | PLoS ONE | 2010 | 78 |
| 46 | Effect of Early Antiretroviral Therapy during Primary HIV-1 Infection on Cell-Associated HIV-1 Dna and Plasma HIV-1 Rna | Antiviral Therapy | 2011 | 77 |
| 47 | Modulation of Staphylococcus aureus Biofilm Matrix by Subinhibitory Concentrations of Clindamycin | Antimicrobial Agents and Chemotherapy | 2016 | 76 |
| 48 | DNase Sda1 Allows Invasive M1T1 Group A Streptococcus to Prevent TLR9-Dependent Recognition | PLoS Pathogens | 2012 | 73 |
| 49 | Humanized Mice Recapitulate Key Features of HIV-1 Infection: A Novel Concept Using Long-Acting Anti-Retroviral Drugs for Treating HIV-1 | PLoS ONE | 2012 | 72 |
| 50 | Hepatitis B Virus Infection Is Associated With Impaired Immunological Recovery During Antiretroviral Therapy in the Swiss HIV Cohort Study | Journal of Infectious Diseases | 2013 | 67 |
